Effects of an anti-TSLP antibody on allergen-induced asthmatic responses.
By G. Gauvreau, P. O'Byrne, L. Boulet, Ying Wang, D. Cockcroft, J. Bigler, J. Fitzgerald, M. Boedigheimer, B. Davis, C. Dias and 6 more. New England Journal of Medicine, 2014
758 citations recorded by the source corpus.
Subfields: Dermatology, Immunology and Allergy, Physiology
View Paper: https://www.semanticscholar.org/paper/3eb53e0cb6fff8aef97146bb02af1e86bc9fbadc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Dermatology
In Immunology and Allergy
In Physiology
Citations in the corpus
- Innate Lymphoid Cells: a new paradigm in immunology (2015, background): “Furthermore, antibodies against IL-25 and IL-33 have shown efficacy in mouse models of allergic lung inflammation (122, 123), and intravenous antibody to TSLP given before allergen challenge in mild asthmatic patients improves asthma symptoms (124).”
- Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases. (2016, background): “TSLP has been reported to play a pivotal role in allergic asthma, with antiTSLP (AMG157) antibody showing promising efficacy in reducing allergen-induced inflammation in primates and human subjects.(149,150) TSLP is also associated with atopic dermatitis.”